223 related articles for article (PubMed ID: 8732438)
1. Pharmacology and pharmacokinetics of citalopram and other SSRIs.
Baumann P
Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():5-11. PubMed ID: 8732438
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
Baumann P
Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
Baumann P; Rochat B
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():15-21. PubMed ID: 7622807
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
Preskorn SH
Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
[TBL] [Abstract][Full Text] [Related]
5. The pharmacogenetics of the selective serotonin reuptake inhibitors.
Brøsen K
Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).
Hyttel J
Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():19-26. PubMed ID: 8021435
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
van Harten J
Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology.
Goodnick PJ; Goldstein BJ
J Psychopharmacol; 1998; 12(3 Suppl B):S5-20. PubMed ID: 9808077
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of selective serotonin reuptake inhibitors.
Hiemke C; Härtter S
Pharmacol Ther; 2000 Jan; 85(1):11-28. PubMed ID: 10674711
[TBL] [Abstract][Full Text] [Related]
10. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Sánchez C; Meier E
Psychopharmacology (Berl); 1997 Feb; 129(3):197-205. PubMed ID: 9084057
[TBL] [Abstract][Full Text] [Related]
11. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
Millan MJ; Veiga S; Girardon S; Brocco M
Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats.
Oosting RS; Chan JS; Olivier B; Banerjee P; Choi YK; Tarazi F
Psychopharmacology (Berl); 2016 Mar; 233(6):1025-34. PubMed ID: 26758283
[TBL] [Abstract][Full Text] [Related]
14. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Sánchez C; Hyttel J
Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
[TBL] [Abstract][Full Text] [Related]
15. Evidence from microdialysis and synaptosomal studies of rat cortex for noradrenaline uptake sites with different sensitivities to SSRIs.
Hughes ZA; Stanford SC
Br J Pharmacol; 1998 Jul; 124(6):1141-8. PubMed ID: 9720784
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of action of antidepressants: new data from Escitalopram].
Fabre V; Hamon M
Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
18. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
Ishima T; Fujita Y; Hashimoto K
Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523
[TBL] [Abstract][Full Text] [Related]
19. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
Owens MJ; Knight DL; Nemeroff CB
Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
[TBL] [Abstract][Full Text] [Related]
20. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
